JPWO2023154705A5 - - Google Patents

Info

Publication number
JPWO2023154705A5
JPWO2023154705A5 JP2024547152A JP2024547152A JPWO2023154705A5 JP WO2023154705 A5 JPWO2023154705 A5 JP WO2023154705A5 JP 2024547152 A JP2024547152 A JP 2024547152A JP 2024547152 A JP2024547152 A JP 2024547152A JP WO2023154705 A5 JPWO2023154705 A5 JP WO2023154705A5
Authority
JP
Japan
Prior art keywords
pharmaceutical
formulation
pharmaceutical composition
administration
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024547152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506019A5 (https=
JP2025506019A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/062136 external-priority patent/WO2023154705A1/en
Publication of JP2025506019A publication Critical patent/JP2025506019A/ja
Publication of JPWO2023154705A5 publication Critical patent/JPWO2023154705A5/ja
Publication of JP2025506019A5 publication Critical patent/JP2025506019A5/ja
Pending legal-status Critical Current

Links

JP2024547152A 2022-02-08 2023-02-07 トレプロスチニルイロプロスト併用療法 Pending JP2025506019A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307919P 2022-02-08 2022-02-08
US63/307,919 2022-02-08
PCT/US2023/062136 WO2023154705A1 (en) 2022-02-08 2023-02-07 Treprostinil iloprost combination therapy

Publications (3)

Publication Number Publication Date
JP2025506019A JP2025506019A (ja) 2025-03-05
JPWO2023154705A5 true JPWO2023154705A5 (https=) 2026-02-05
JP2025506019A5 JP2025506019A5 (https=) 2026-02-05

Family

ID=85510816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024547152A Pending JP2025506019A (ja) 2022-02-08 2023-02-07 トレプロスチニルイロプロスト併用療法

Country Status (9)

Country Link
US (1) US20230263807A1 (https=)
EP (1) EP4475819A1 (https=)
JP (1) JP2025506019A (https=)
KR (1) KR20240141319A (https=)
CN (1) CN118984697A (https=)
AU (1) AU2023219692A1 (https=)
CA (1) CA3243453A1 (https=)
IL (1) IL314791A (https=)
WO (1) WO2023154705A1 (https=)

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485614A (en) 1946-08-29 1949-10-25 Chicago Bridge & Iron Co Stabilizing and guide apparatus for lifter roofs
US3037116A (en) 1957-07-26 1962-05-29 Weber Georges Apparatus for irradiating liquids
US3035516A (en) 1958-08-18 1962-05-22 Lee Brothers Company Stencil device
US3646509A (en) 1969-08-08 1972-02-29 Texas Instruments Inc Method for field stacking seismic data and system using write after read bulk data storage
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4547016A (en) 1984-08-13 1985-10-15 Eeco Incorporated Quick release mounting
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
IT1231076B (it) 1989-09-28 1991-11-12 Pirelli Cavi Spa Procedimento per la realizzazione di gruppo di connessione separabile per fibre ottiche riunite a nastro e gruppo di connessione con esso realizzato.
GB9011588D0 (en) 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
EP1045695B1 (en) 1997-11-14 2004-03-24 United Therapeutics Corporation Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
CN1354622A (zh) 1999-03-31 2002-06-19 联合治疗公司 前列腺素类化合物、组合物和治疗外周血管疾病和肺动脉高压的方法
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US6756117B1 (en) 2002-12-20 2004-06-29 The United States Of America As Represented By The United States Department Of Energy Photonic polymer-blend structures and method for making
CN101265226B (zh) 2003-05-22 2013-04-24 联合治疗公司 化合物和释放前列环素类似物的方法
CN1917866B (zh) 2003-12-16 2010-12-15 联合治疗公司 曲前列环素或它的衍生物,或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
CA2549801C (en) 2003-12-16 2012-10-16 United Therapeutics Corporation Use of treprostinil to improve kidney functions
ATE462427T1 (de) 2004-04-12 2010-04-15 United Therapeutics Corp Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
MX2007000979A (es) * 2004-07-26 2007-07-11 Cotherix Inc Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada.
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
CN101495122B (zh) * 2006-05-15 2011-10-05 联合治疗公司 使用定量吸入器给予曲前列尼
CA2698721A1 (en) 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
KR20160048222A (ko) 2007-12-17 2016-05-03 유나이티드 세러퓨틱스 코오포레이션 레모둘린?의 활성 성분인 트레프로스티닐의 개선된 제조 방법
US8350079B2 (en) 2008-05-08 2013-01-08 United Therapeutics Corporation Treprostinil formulation
CN101827626B (zh) 2008-06-13 2015-03-18 曼金德公司 干粉吸入器和用于药物输送的系统
JP5649645B2 (ja) 2009-05-07 2015-01-07 ユナイテッド セラピューティクス コーポレイション プロスタサイクリンアナログの固形製剤
EP3108888B1 (en) 2010-03-15 2020-02-12 United Therapeutics Corporation Treatment for pulmonary hypertension
US20130040898A1 (en) * 2010-04-29 2013-02-14 Pär Johansson Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
WO2011153363A1 (en) 2010-06-03 2011-12-08 United Therapeutics Corporation Treprostinil production
CA2710725C (en) 2010-07-22 2017-08-01 Alphora Research Inc. Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
EP2681204B1 (en) 2011-03-02 2016-04-27 United Therapeutics Corporation Synthesis of intermediate for treprostinil production
US9388154B2 (en) 2011-09-12 2016-07-12 Lund Biotechnology PBC Process for preparing synthetic prostacyclins
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
PL2674413T3 (pl) 2012-06-15 2018-05-30 Scipharm Sàrl Sposób wytwarzania treprostynilu i jego pochodnych
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
CN105407883A (zh) 2013-04-30 2016-03-16 联合治疗学有限公司 控释药物制剂
LT3060041T (lt) 2013-10-25 2021-03-25 Insmed Incorporated Prostaciklino junginiai
WO2015081147A1 (en) 2013-11-27 2015-06-04 Corning Incorporated Composition for improved manufacture of substrates
WO2015138423A1 (en) * 2014-03-11 2015-09-17 Insmed Incorporated Prostacylin compositions and methods for using the same
WO2015174197A1 (ja) 2014-05-14 2015-11-19 富士電機株式会社 半導体装置および半導体装置の製造方法
WO2016038532A1 (en) 2014-09-09 2016-03-17 Mylan Laboratories Limited Amorphous treprostinil diethanolamine
HU231184B1 (hu) 2014-10-08 2021-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
ES2778274T3 (es) 2014-10-20 2020-08-10 United Therapeutics Corp Síntesis de productos intermedios para producir derivados de prostaciclina
JP6866043B2 (ja) 2014-11-18 2021-04-28 インスメッド インコーポレイテッド トレプロスチニルプロドラッグおよびトレプロスチニル誘導体プロドラッグの製造方法
US10837038B2 (en) 2014-12-23 2020-11-17 National Technology & Engineering Solutions Of Sandia, Llc Adjusting the pH of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
EP3442062A4 (en) 2016-04-08 2019-12-18 Idemitsu Kosan Co., Ltd. BINDING AGENT FOR ELECTROCHEMICAL ELEMENT
US10898494B2 (en) * 2016-05-05 2021-01-26 Liquidia Technologies, Inc. Dry powder treprostinil for the treatment of pulmonary hypertension
JP7220650B2 (ja) 2016-09-26 2023-02-10 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグ
KR20260020212A (ko) * 2016-11-10 2026-02-10 아레나 파마슈티칼스, 인크. 라리네팍 및 다른 제제의 조합에 의한 pah의 치료 방법
CA3102967A1 (en) 2018-06-07 2019-12-12 Mannkind Corporation Composition and method for inhalation
JP2022546314A (ja) 2019-08-23 2022-11-04 ユナイテッド セラピューティクス コーポレイション トレプロスチニルプロドラッグ
AU2021255621A1 (en) 2020-04-17 2022-10-20 United Therapeutics Corporation Treprostinil for use in the treatment of intersitial lung disease
JP7608480B2 (ja) 2020-06-09 2025-01-06 ユナイテッド セラピューティクス コーポレイション トレプロスチニルのフマリルジケトピペリジンプロドラッグ

Similar Documents

Publication Publication Date Title
JP7621220B2 (ja) 疾患の処置のための鼻腔内エピネフリン製剤及び方法
JP2024095678A5 (https=)
US20010041190A1 (en) Method for pulmonary and oral delivery of pharmaceuticals
JP2019528320A5 (https=)
CA3035528A1 (en) Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
JP2015129177A (ja) 肺深部へのトレプロスチニルの肺送達
RU2685706C2 (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
KR102375232B1 (ko) 비강내 에피네프린 제제 및 질환의 치료 방법
CN116635018A (zh) 吸入用药物组合物
KR20030031997A (ko) 살메테롤과 플루티카손 프로피오네이트의 약제학적포뮬레이션
KR20230005937A (ko) 바이러스 감염의 치료 또는 예방을 위한 클로파지민 조성물 및 방법
WO2017101696A1 (zh) 治疗急慢性呼吸困难的西药组合物及其制备方法
JPWO2023154705A5 (https=)
JP7309791B2 (ja) イソグリチルリチン酸またはその塩の吸入製剤および呼吸器疾患を治療する薬物の製造におけるそれらの使用
US20150250779A1 (en) Agent for Ameliorating Chronic Obstructive Pulmonary Disease
JP2021176903A5 (https=)
CN107137502A (zh) 一种鱼腥草雾化吸入用溶液制剂及其制备方法
EP4051307B1 (en) Peptide for prevention or treatment of covid-19
US20230263807A1 (en) Treprostinil iloprost combination therapy
Jendle et al. An exploration of intrapulmonary insulin administration in anaesthetized and mechanically ventilated pigs
Bernstein et al. Therapeutic uses of lung aerosol
HK40083799A (en) Clofazimine composition and method for the treatment or prophylaxis of viral infections
RU2326670C1 (ru) Способ комплексной интенсивной терапии острого стенозирующего ларинготрахеита у детей
CN121487728A (zh) 喷雾干燥的曲前列环素制剂
WO2024054226A1 (en) Gallium nitrate and dimethyl sulfoxide composition for respiratory treatment